Biotechnology Assets S.A.

BST · MC · Healthcare / Biotechnology

0.216EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.216

Open0.216

Day Range0.208 – 0.216

52-Week Range0.176 – 0.431

Volume19.98K

Market Cap14.11M

P/E (TTM)0.00

Forward P/E7.42

EPS-0.03

Dividend Yield0.00%

Beta1.82

50-Day Avg0.2167

200-Day Avg0.2228

About

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a solution for site-specific conjugation of proteins; Click Car for Split-CARs universal connectors; VACC-ZERA, a tool to generate recombinant proteins in microparticles; and CLICK'N CUT for tag-less protein purification. The company is based in Cádiz, Spain.

Company Details

SectorHealthcare
IndustryBiotechnology
CEODr. Manuel Lopez Nieto
Employees26
HeadquartersAv. del Desarrollo Tecnológico, 11, Cádiz, Spain, 11591, Spain
Websitehttps://www.biatgroup.com

Leadership

Dr. Manuel Lopez NietoChief Technical Officer

Financials

Income Statement

Currency: EUR	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	137.97K	289.15K	443.17K	870.46K	1.88M	1.05M	1.31M	2.39M	23.32M	41.83M	2.52M	3.09M	2.61M	3.91M	2.51M	3.09M
Growth (%)	-	+109.57%	+53.27%	+96.42%	+116.04%	-44.15%	+24.94%	+82.04%	+876.06%	+79.38%	-93.96%	+22.21%	-15.28%	+49.53%	-35.66%	+22.91%
Cost of Revenue	-260.62K	-499.69K	-489.25K	-449.84K	-735.74K	-686.75K	-1.18M	-889.88K	8.70M	15.82M	-196.76K	49.78K	-20.86K	450.59K	-138.41K	3.60M
Gross Profit	398.60K	788.84K	932.42K	1.32M	2.62M	1.74M	2.49M	3.28M	14.61M	26.01M	2.72M	3.04M	2.63M	3.46M	2.65M	-512.16K
Gross Margin	288.90%	272.81%	210.40%	151.68%	139.12%	165.38%	189.54%	137.25%	62.68%	62.18%	107.79%	98.39%	100.80%	88.47%	105.50%	-16.57%
Operating Expense	459.09K	864.07K	1.69M	1.10M	2.28M	2.33M	4.16M	3.54M	29.56M	32.72M	3.93M	5.11M	905.72K	803.81K	-54.89K	1.39M
Operating Income	-60.49K	-75.23K	-762.31K	218.62K	331.60K	-588.95K	-1.67M	-263.82K	-14.95M	-6.71M	-1.21M	-2.07M	1.73M	2.65M	2.71M	-1.90M
Operating Margin	-43.85%	-26.02%	-172.01%	25.12%	17.63%	-56.07%	-127.39%	-11.04%	-64.10%	-16.04%	-47.87%	-67.21%	66.15%	67.91%	107.69%	-61.59%
EBITDA	-189.69K	220.10K	-246.31K	818.26K	1.60M	42.28K	-459.74K	-10.19M	-11.08M	1.76M	993.11K	-25.03K	450.40K	5.10M	-670.76K	112.52K
EBITDA Margin	-137.48%	76.12%	-55.58%	94.00%	84.82%	4.03%	-35.03%	-426.58%	-47.51%	4.21%	39.34%	-0.81%	17.23%	130.46%	-26.67%	3.64%
Net Income	553.35K	308.14K	-342.08K	473.06K	1.19M	-192.60K	-1.14M	-73.39K	-16.69M	-10.08M	-8.61M	-3.01M	-1.94M	1.57M	-2.92M	-1.92M
Net Income Margin	401.07%	106.57%	-77.19%	54.35%	63.46%	-18.34%	-86.55%	-3.07%	-71.60%	-24.10%	-340.91%	-97.65%	-74.35%	40.27%	-116.02%	-61.99%
R&D	-	-	-	-	-	-	219.40K	126.00K	94.48K	39.48K	47.51K	20.29K	18.22K	1.45M	1.21M	7.84K
R&D as % of Total Revenue	-	-	-	-	-	-	16.72%	5.27%	0.41%	0.09%	1.88%	0.66%	0.70%	37.12%	48.04%	0.25%
Interest Expense	35.41K	129.59K	170.08K	159.73K	239.28K	104.72K	1.26M	1.01M	1.23M	3.27M	333.36K	854.67K	345.45K	310.97K	181.27K	170.42K
Interest Expense % of Total Revenue	25.66%	44.82%	38.38%	18.35%	12.72%	9.97%	96.25%	42.23%	5.29%	7.81%	13.20%	27.70%	13.22%	7.96%	7.21%	5.51%

Balance Sheet

Currency: EUR	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	5.03M	7.29M	7.61M	9.25M	14.68M	14.80M	15.97M	17.58M	79.24M	92.67M	20.21M	19.88M	18.47M	16.61M	14.78M	13.56M
Total Liabilities	2.84M	4.69M	4.76M	5.00M	7.01M	7.23M	8.02M	9.56M	58.04M	85.11M	16.37M	15.54M	14.60M	10.08M	8.17M	6.60M
Total Equity	2.19M	2.60M	2.86M	4.24M	7.68M	7.57M	8.05M	8.16M	21.19M	7.71M	3.99M	4.49M	4.03M	6.68M	6.61M	6.18M
Cash	21.36K	1.42M	116.63K	575.58K	1.12M	444.82K	159.02K	505.17K	3.95M	2.62M	555.97K	1.68M	692.11K	311.12K	143.82K	422.47K
Total Debt	7.34	-	373.46K	459.84K	5.78M	6.07M	1.17M	1.16M	46.80M	19.47M	3.21M	3.58M	3.72M	7.13M	5.13M	1.74M
Net Debt	-21.37K	-1.42M	256.83K	-115.74K	4.66M	5.62M	1.01M	657.50K	42.85M	16.85M	2.65M	1.90M	3.03M	6.81M	4.99M	1.32M

Cash Flow

Currency: EUR	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-303.79K	158.16K	2.71M	213.49K	-13.02M	-15.16M	8.79M	-1.50M	-1.73M	47.74K	-73.85K	-13.11K
Investing Cash Flow	-829.96K	-1.13M	-3.30M	-1.45M	-9.69M	-7.48M	44.84M	-661.46K	-211.52M	-325.97K	-720.73K	-342.93K
Financing Cash Flow	1.68M	292.13K	304.50K	1.58M	24.16M	23.50M	-57.84M	3.28M	114.75M	-61.01K	637.84K	582.38K
Capital Expenditure	641.86K	1.07M	3.27M	1.56M	11.19M	7.48M	391.53K	661.46K	211.52M	325.97K	720.73K	1.98K
Free Cash Flow	-945.64K	-910.02K	-555.22K	-1.35M	-24.22M	-22.64M	8.40M	-2.16M	-213.25M	-278.23K	-794.57K	-15.09K
Dividends Paid	97.70K	-	-	-	-	-	-	961.50K	59.00M	-	-	-
FCF to OCF	311.28%	-575.40%	-20.45%	-633.00%	185.95%	149.36%	95.55%	144.04%	12304.68%	-582.81%	1075.94%	115.11%
Dividend Paid to FCF	-10.33%	-	-	-	-	-	-	-44.44%	-27.67%	-	-	-

Key Statistics & Ratios

Market Cap14.11M

Enterprise Value19.47M

Trailing P/E0.00

Forward P/E7.42

Price / Sales4.11

Price / Book2.31

EPS-0.03

Book Value0.096

Revenue (TTM)3.43M

Gross Profit (TTM)3.17M

EBITDA-100.43K

Profit Margin-55.83%

Operating Margin-0.04%

Return on Equity-28.25%

Return on Assets-4.53%

Shares Outstanding75.03M

Shares Float36.70M

Beta1.82

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20221×

0.13Jun 6, 2022